Back in Boston!
The 4th Inflammasome Therapeutics Summit is the only industry-led forum for biopharma to accelerate the practical translation and clinical development of inflammasome-targeted drugs that are shaking up the immunology R&D landscape.
We all know that digital events don't carry the same opportunity and excitement as being fully amongst your community for days at a time. That's why we're so delighted to be back in Boston this November.
Here's a reminder of what you can expect from a physical 4th Inflammasome Therapeutics Summit
Testimonials from Recent Related In-Person Events:
"Discussing common challenges and working together to face them is extremely motivating."
Josh Woodburn, Senior Manager - Outsourced Manufacturing, Notch Therapeutics
"Great opportunity to meet in person with colleagues to discuss challenges facing the cell therapy industry."
Jason Acker, Professor - Laboratory Medicine & Pathology, University of Alberta
"I learned a lot from the knowledgeable presenters, participants and service providers, and I enjoyed reconnecting and making new connections with other cell therapy developers."
Elena Spanjaard, Vice President Early Development Regulatory Affairs, Elevate Bio
"Best networking conference I have ever attended!"
Kelvin Brockbank, Chief Executive Officer, Tissue Testing Technologies
"Very good interaction, presentations and opportunity to network!"
James Glover, Senior Vice President - Internal & External Manufacturing, Athersys
"This was an excellent conference for connecting with colleagues involved in the field of allogeneic cell therapies - agenda was well-thought out and structured to support attendees participating in those sessions that were of highest relevance to their area of expertise."
Melissa Sebok, Executive Director, Product, Client & Business Development, Direct Patient Care & Emerging Offerings, American Red Cross